BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24613906)

  • 1. Correlation between expression of biological markers and [F]fluorodeoxyglucose uptake in endometrial cancer.
    Jo MS; Choi OH; Suh DS; Yun MS; Kim SJ; Kim GH; Jeon HN
    Oncol Res Treat; 2014; 37(1-2):30-4. PubMed ID: 24613906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between biological marker expression and F-fluorodeoxyglucose uptake in cervical cancer measured by positron emission tomography.
    Park SI; Suh DS; Kim SJ; Choi KU; Yoon MS
    Onkologie; 2013; 36(4):169-74. PubMed ID: 23548964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1α, adrenomedullin and Bcl-2 although expected are not related to increased uptake of fluorine-18-fluorodeoxyglucose in endometrial cancer.
    Cerci SS; Yalcin Y; Bozkurt KK; Erdemoglu E; Tatar B; Erdemoglu E
    Hell J Nucl Med; 2015; 18(3):228-32. PubMed ID: 26637502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
    Bos R; van Der Hoeven JJ; van Der Wall E; van Der Groep P; van Diest PJ; Comans EF; Joshi U; Semenza GL; Hoekstra OS; Lammertsma AA; Molthoff CF
    J Clin Oncol; 2002 Jan; 20(2):379-87. PubMed ID: 11786564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
    Kaira K; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Hayashi I; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
    Eur J Radiol; 2012 Sep; 81(9):2423-9. PubMed ID: 22055682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
    Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J
    Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
    Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in incidentally detected thyroid cancer.
    Kim BH; Kim IJ; Kim SS; Kim SJ; Lee CH; Kim YK
    Cancer Biother Radiopharm; 2010 Jun; 25(3):309-15. PubMed ID: 20578836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
    Yamada T; Uchida M; Kwang-Lee K; Kitamura N; Yoshimura T; Sasabe E; Yamamoto T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):464-71. PubMed ID: 22676927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between ¹⁸F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1α in transplanted VX2 tumors.
    Xu H; Li B; Yu W; Wang H; Zhao X; Yao Y; Huang D
    Nucl Med Commun; 2013 Oct; 34(10):953-8. PubMed ID: 23887273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer.
    Nakamura K; Kodama J; Okumura Y; Hongo A; Kanazawa S; Hiramatsu Y
    Int J Gynecol Cancer; 2010 Jan; 20(1):110-5. PubMed ID: 20130510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors.
    Kaira K; Okumura T; Ohde Y; Takahashi T; Murakami H; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
    J Nucl Med; 2011 May; 52(5):705-11. PubMed ID: 21498541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer.
    Mees G; Vangestel C; Dierckx R; Pauwels P; Van Meerbeeck J; Van de Wiele C
    Cancer Biother Radiopharm; 2010 Apr; 25(2):149-54. PubMed ID: 20423227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of (18)F-FDG imaging and serum tumor markers in the diagnosis of recurrent endometrial carcinoma].
    Wang Q; Hong L; Wang JL; Yue MG; Li HB; Li Y
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):300-3. PubMed ID: 20510085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
    Zhao S; Kuge Y; Mochizuki T; Takahashi T; Nakada K; Sato M; Takei T; Tamaki N
    J Nucl Med; 2005 Apr; 46(4):675-82. PubMed ID: 15809491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.
    Schreurs LM; Smit JK; Pavlov K; Pultrum BB; Pruim J; Groen H; Hollema H; Plukker JT
    Ann Surg Oncol; 2014 Nov; 21(12):3751-7. PubMed ID: 24939624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.
    Paudyal B; Oriuchi N; Paudyal P; Higuchi T; Nakajima T; Endo K
    Cancer Sci; 2008 Feb; 99(2):260-6. PubMed ID: 18271924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
    Lee DW; Chong GO; Lee YH; Hong DG; Cho YL; Jeong SY; Park JY; Lee YS
    Int J Gynecol Cancer; 2015 Jun; 25(5):843-9. PubMed ID: 25347093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.
    Christlieb SB; Strandholdt CN; Olsen BB; Mylam KJ; Larsen TS; Nielsen AL; Rohde M; Gerke O; Olsen KE; Møller MB; Kristensen BW; Abildgaard N; Alavi A; Høilund-Carlsen PF
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1824-36. PubMed ID: 27102266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.